Loading, Please Wait...
WILMINGTON, Del., April 09, 2019 (GLOBE NEWSWIRE) -- Rigrodsky & Long, P.A.:
Rigrodsky & Long, P.A. announces that it has filed a class action complaint in the United States District Court for the District of Delaware on behalf of holders of Ohr Pharmaceutical, Inc. (“Ohr”) (NasdaqCM: OHRP) common stock in connection with the proposed merger of Ohr and NeuBase Therapeutics, Inc. (“NeuBase”) announced on January 3, 2019 (the “Complaint”). The Complaint, which alleges violations of the Securities Exchange Act of 1934 against Ohr, its Board of Directors (the “Board”), and NeuBase, is captioned Wheby v. Ohr Pharmaceutical, Inc., Case No. 1:19-cv-00541 (D. Del.).
If you wish to discuss this action or have any questions concerning this notice or your rights or interests, please contact plaintiff’s counsel, Seth D. Rigrodsky or Gina M. Serra at Rigrodsky & Long, P.A., 300 Delaware Avenue, Suite 1220, Wilmington, DE 19801, by telephone at (888) 969-4242, by e-mail at email@example.com, or at http://rigrodskylong.com/contact-us/.
On February 2, 2019, Ohr entered into an agreement and plan of merger (the “Merger Agreement”) with NeuBase. Under the exchange ratio formula in the Merger Agreement, the former NeuBase securityholders are expected to own approximately 80% of the aggregate number of shares of the Company common stock issued and outstanding following the consummation of the merger, and the stockholders of the Company as of immediately prior to the merger are expected to own approximately 20% of the aggregate number of post-closing shares (the “Proposed Transaction”).
Among other things, the Complaint alleges that, in an attempt to secure shareholder support for the Proposed Transaction, defendants issued materially incomplete disclosures in a registration statement (the “Registration Statement”) filed with the United States Securities and Exchange Commission. The Complaint alleges that the Registration Statement omits material information with respect to, among other things, the Company’s and NeuBase’s financial projections and the analyses performed by Ohr’s financial advisor. The Complaint seeks injunctive and equitable relief and damages on behalf of holders of Ohr common stock.
If you wish to serve as lead plaintiff, you must move the Court no later than June 10, 2019. A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation. Any member of the proposed class may move the Court to serve as lead plaintiff through counsel of their choice, or may choose to do nothing and remain an absent class member.
Rigrodsky & Long, P.A., with offices in Delaware, New York, and California, has recovered hundreds of millions of dollars on behalf of investors and achieved substantial corporate governance reforms in numerous cases nationwide, including federal securities fraud actions, shareholder class actions, and shareholder derivative actions.
Attorney advertising. Prior results do not guarantee a similar outcome.